Here is My Question:
I’m asking this question out of frustration of results from overpriced medications Ampyra and Copaxone. SARMS and peptides seem to have some benefits for people with MS. Has the medical community looked at this opportunity?
SARMS, also known as Selective Androgen Receptor Modulators, are not approved by the FDA and are under investigation for a number of conditions including MS. My understanding is that the unregulated product people buy on line is often not what they promise it to be. Whether these drugs will be of any benefit is unknown at present. Not sure what “peptide” therapies you are referring to in your question.
Revere (Rip) Kinkel MD
Professor of Clinical Neurosciences
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
University of California San Diego
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.